Elizabeth Ergen is a Dermatology physician affiliated with Johnson & Johnson. OpenAlex indexes 31 publications with 541 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
D3100 Medical Ctr N
Nashville, TN 372320001
Telephone
615-343-0339Provider last certified this registry record 6 Apr 2026.
Industry payments
29 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Regeneron Healthcare Solutions, Inc.Program year20255 payments
- UCB, Inc.Program year20256 payments
- BioWound Solutions, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
19.4%Azole Antifungal11.1%Ketoconazole79%Fluconazole21%Part D<11 patientsFirst-generation cephalosporins4.7%Cephalexin100%Part D≥11 patients+ 1 more class in this area
Sensory organs
19.2%Corticosteroid16.6%Clobetasol Propionate80%Hydrocortisone20%Part D≥25 patientsAminoglycoside Antibacterial2.6%Gentamicin Sulfate100%Part D<11 patientsDermatology
17.4%Interleukin-4 Receptor alpha Antagonist8.5%Dupixent Pen67%Dupixent Syringe33%Part D<11 patientsCorticosteroid4.5%Triamcinolone Acetonide100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- HLA-B Alleles With Shared Peptide Binding Specificities Define Global Risk of Co-trimoxazole-Induced Severe Cutaneous Adverse Drug Reactions
The Journal of Allergy and Clinical Immunology In Practice
2025 - Long-term morbidity and quality of life in survivors of Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum
British Journal of Dermatology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Wayne Drevets, MD
Johnson & Johnson
Matthew Breyer, MD
Johnson & Johnson
Deepu Madduri, MD
Johnson & Johnson
Elliot Barnathan, MD
Johnson & Johnson
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”